Literature DB >> 19066785

[Transient pruritus in an Ethiopean adoptee in Austria].

Rosemarie Moser1, Herbert Auer, Christina Prenner-Glas, Georg Klein.   

Abstract

Strongyloidosis is highly endemic in humid tropical regions of the world and therefore should be considered in symptomatic travellers or immigrants. Clinical characteristics, diagnostic procedures and therapeutic options are discussed on the basis of a case report on a three years old adoptee from Ethiopia. In immunocompetent hosts the infection causes transient pruritic urticarial serpiginous lesions mostly located on the buttocks or lower extremities and unspecific gastrointestinal symptoms. In immunocompromised patients the infection can generalize and lead to hyperinfection, a syndrome lethal in up to 85% of patients. Diagnostic work up should include a white blood cell count and differential as well as serology. In case of eosinophilia and positive serology, detection of larvae with a concentration technique in minimum three stool samples should be performed. Ivermectin and Albendazole can be used for treatment. Response to treatment should be assessed by serology and eosinophil count three to six months after therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066785     DOI: 10.1007/s00508-008-1081-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  35 in total

1.  Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin.

Authors:  Jackson Orem; Billy Mayanja; Martin Okongo; Dilys Morgan
Journal:  Clin Infect Dis       Date:  2003-07-01       Impact factor: 9.079

Review 2.  Intestinal strongyloidiasis: recognition, management, and determinants of outcome.

Authors:  Ronald Concha; William Harrington; Arvey I Rogers
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

3.  Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host.

Authors:  S M Gordon; A A Gal; A R Solomon; J A Bryan
Journal:  J Am Acad Dermatol       Date:  1994-08       Impact factor: 11.527

Review 4.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

5.  Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country.

Authors:  Sonali Sudarshi; Richard Stümpfle; Margaret Armstrong; Thomas Ellman; Simon Parton; Prabha Krishnan; Peter L Chiodini; Christopher J M Whitty
Journal:  Trop Med Int Health       Date:  2003-08       Impact factor: 2.622

Review 6.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method.

Authors:  Tetsuo Hirata; Hiroshi Nakamura; Nagisa Kinjo; Akira Hokama; Fukunori Kinjo; Nobuhisa Yamane; Jiro Fujita
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

8.  Cutaneous Strongyloides stercoralis infection: an unusual presentation.

Authors:  Micki N Ly; Shauna L Bethel; Arif S Usmani; David R Lambert
Journal:  J Am Acad Dermatol       Date:  2003-08       Impact factor: 11.527

9.  Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey.

Authors:  David R Boulware; William M Stauffer; Brett R Hendel-Paterson; Jaime Luís Lopes Rocha; Raymond Chee-Seong Seet; Andrea P Summer; Linda S Nield; Khuanchai Supparatpinyo; Romanee Chaiwarith; Patricia F Walker
Journal:  Am J Med       Date:  2007-06       Impact factor: 4.965

Review 10.  Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease.

Authors:  R M Genta
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.